Auto-Contouring of High-Risk Clinical Target Volume and Organ-at-Risks for Cervical Cancer HDR

被引:0
|
作者
Lei, Y. [1 ]
Chao, M. [2 ]
Yang, K. [1 ]
Gupta, V. [1 ]
Yoshida, E. [3 ]
Wang, T. [1 ]
Yang, X. [4 ]
Liu, T. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] Mt Sinai Hlth Syst, New York, NY USA
[3] Univ Calif San Francisco, San Francisco, CA USA
[4] Emory Univ, Atlanta, GA USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
TU300-GPD(
引用
收藏
页码:7686 / 7686
页数:1
相关论文
共 50 条
  • [31] Delineation of clinical target volume and organs at risk in cervical cancer radiotherapy by deep learning networks
    Tian, Miao
    Wang, Hongqiu
    Liu, Xingang
    Ye, Yuyun
    Ouyang, Ganlu
    Shen, Yali
    Li, Zhiping
    Wang, Xin
    Wu, Shaozhi
    MEDICAL PHYSICS, 2023, 50 (10) : 6354 - 6365
  • [32] Dosimetric Comparison of Organs at Risk when using Different Contouring Guidelines to Define the clinical Target Volume in Anal Cancer
    Dapper, H.
    Oechsner, M.
    Muench, S.
    Peeken, J.
    Borm, K.
    Diehl, C.
    Combs, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S12 - S13
  • [33] Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging
    Yuan, Xingxing
    Yan, Chao
    Peng, Shiyi
    Chen, Zhiping
    Lu, Tianzhu
    Gong, Qiaoying
    Qiu, Yang
    Xiong, Wenming
    Ao, Fenghua
    Li, Guoqing
    Li, Jingao
    Tu, Ziwei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] 'Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study ' (vol 73 , 103599, 2024)
    Choi, Min Seo
    Chang, Jee Suk
    Kim, Kyubo
    Kim, Jin Hee
    Kim, Tae Hyung
    Kim, Sungmin
    Cha, Hyejung
    Cho, Oyeon
    Choi, Jin Hwa
    Kim, Myungsoo
    Kim, Juree
    Kim, Tae Gyu
    Yeo, Seung-Gu
    Chang, Ah Ram
    Ahn, Sung-Ja
    Choi, Jinhyun
    Kang, Ki Mun
    Kwon, Jeanny
    Koo, Taeryool
    Kim, Mi Young
    Choi, Seo Hee
    Jeong, Bae Kwon
    Jang, Bum-Sup
    Jo, In Young
    Lee, Hyebin
    Kim, Nalee
    Park, Hae Jin
    Im, Jung Ho
    Lee, Sea-Won
    Cho, Yeona
    Lee, Sun Young
    Chang, Ji Hyun
    Chun, Jaehee
    Lee, Eung Man
    Kim, Jin Sung
    Shin, Kyung Hwan
    Kim, Yong Bae
    BREAST, 2024, 74
  • [35] Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer
    Zhang, Jingjing
    Cao, Dongyan
    Yang, Jiaxin
    Shen, Keng
    He, Yonglan
    Xue, Huadan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Construction and Selection of the Automatic Segmentation Tools for High-Risk Clinical Tumor Volume in Brachytherapy for Cervical Cancer Based on Deep Learning
    Ma, C. Y.
    Zhang, L.
    Wang, Y.
    Jia, L. C.
    Xiong, W. Q.
    Zhang, W.
    Xu, X.
    Zhou, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E643 - E643
  • [37] Dynamics of high risk clinical target volume reduction during brachytherapy and impact on its coverage in patients with inoperable cervical cancer
    Pobijakova, M.
    Scepanovic, D.
    Paluga, M.
    Fekete, M.
    Mardiak, J.
    NEOPLASMA, 2018, 65 (03) : 425 - 430
  • [38] Design and Verification of a Contouring Atlas to Define the Clinical Target Volume for the Para-aortic Lymph Node Region in Patients With Cervical Cancer
    Keenan, L. G.
    Rock, K.
    Azmi, A. F. Mohd
    Salib, O.
    Gillham, C.
    McArdle, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E297 - E298
  • [39] Optimization of supraclavicular lymph node clinical target volume delineation in high-risk breast cancer: a single center experience and recommendation
    Li, Li
    Zhang, Hongyan
    Wang, Linwei
    Xie, Conghua
    Yu, Haijun
    Zhong, Yahua
    BMC CANCER, 2023, 23 (01)
  • [40] Optimization of supraclavicular lymph node clinical target volume delineation in high-risk breast cancer: a single center experience and recommendation
    Li Li
    Hongyan Zhang
    Linwei Wang
    Conghua Xie
    Haijun Yu
    Yahua Zhong
    BMC Cancer, 23